最新的帖子

十二月 23, 2020

Container Closure Integrity Evaluation for Cell and Gene Therapies

With the growth of gene and cell therapies, there is an increased need to characterize container closure systems (CCS) at the low temperatures experienced during their lifecycles: ultra-low (-80°C) for genes and cryogenic (-180°C) for cells. West’s Integrated Solutions platform includes the state-of-the-art container closure integrity (CCI) capabilities needed for these therapies.
Olga Laskina

Olga Laskina, PhD.

Sr. Technical Account Specialist, TCS NA

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • 以前的博客
    Patient with nurse getting treatment

    九月 16, 2020

    Why a Diagnosis of Leukemia Means a Possibly Complicated Journey Ahead

    Victoria Morgan

    Victoria Morgan

    Director, Segment Marketing, Global Biologics

    Daikyo D Sigma Pistons

    八月 21, 2020

    Daikyo D Sigma® 1mL Long Pistons – Performance Excellence

    Katie Espenshade

    Katie Espenshade

    Sr. Technical Account Manager, TCS, NA

    Load more